Ye Si-Ting, Shang Xian-Wen, Huang Yu, Zhu Susan, Zhu Zhuo-Ting, Zhang Xue-Li, Wang Wei, Tang Shu-Lin, Ge Zong-Yuan, Yang Xiao-Hong, He Ming-Guang
The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou 510120, Guangdong Province, China.
Department of Ultrasound, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, Guangdong Province, China.
World J Diabetes. 2024 Apr 15;15(4):697-711. doi: 10.4239/wjd.v15.i4.697.
The importance of age on the development of ocular conditions has been reported by numerous studies. Diabetes may have different associations with different stages of ocular conditions, and the duration of diabetes may affect the development of diabetic eye disease. While there is a dose-response relationship between the age at diagnosis of diabetes and the risk of cardiovascular disease and mortality, whether the age at diagnosis of diabetes is associated with incident ocular conditions remains to be explored. It is unclear which types of diabetes are more predictive of ocular conditions.
To examine associations between the age of diabetes diagnosis and the incidence of cataract, glaucoma, age-related macular degeneration (AMD), and vision acuity.
Our analysis was using the UK Biobank. The cohort included 8709 diabetic participants and 17418 controls for ocular condition analysis, and 6689 diabetic participants and 13378 controls for vision analysis. Ocular diseases were identified using inpatient records until January 2021. Vision acuity was assessed using a chart.
During a median follow-up of 11.0 years, 3874, 665, and 616 new cases of cataract, glaucoma, and AMD, respectively, were identified. A stronger association between diabetes and incident ocular conditions was observed where diabetes was diagnosed at a younger age. Individuals with type 2 diabetes (T2D) diagnosed at < 45 years [HR (95%CI): 2.71 (1.49-4.93)], 45-49 years [2.57 (1.17-5.65)], 50-54 years [1.85 (1.13-3.04)], or 50-59 years of age [1.53 (1.00-2.34)] had a higher risk of AMD independent of glycated haemoglobin. T2D diagnosed < 45 years [HR (95%CI): 2.18 (1.71-2.79)], 45-49 years [1.54 (1.19-2.01)], 50-54 years [1.60 (1.31-1.96)], or 55-59 years of age [1.21 (1.02-1.43)] was associated with an increased cataract risk. T2D diagnosed < 45 years of age only was associated with an increased risk of glaucoma [HR (95%CI): 1.76 (1.00-3.12)]. HRs (95%CIs) for AMD, cataract, and glaucoma associated with type 1 diabetes (T1D) were 4.12 (1.99-8.53), 2.95 (2.17-4.02), and 2.40 (1.09-5.31), respectively. In multivariable-adjusted analysis, individuals with T2D diagnosed < 45 years of age [β 95%CI: 0.025 (0.009,0.040)] had a larger increase in LogMAR. The β (95%CI) for LogMAR associated with T1D was 0.044 (0.014, 0.073).
The younger age at the diagnosis of diabetes is associated with a larger relative risk of incident ocular diseases and greater vision loss.
众多研究报告了年龄在眼部疾病发展中的重要性。糖尿病可能与眼部疾病的不同阶段有不同关联,且糖尿病病程可能影响糖尿病眼病的发展。虽然糖尿病诊断时的年龄与心血管疾病风险和死亡率之间存在剂量反应关系,但糖尿病诊断时的年龄是否与新发眼部疾病相关仍有待探索。目前尚不清楚哪种类型的糖尿病对眼部疾病更具预测性。
研究糖尿病诊断年龄与白内障、青光眼、年龄相关性黄斑变性(AMD)发病率及视力之间的关联。
我们使用英国生物银行进行分析。该队列包括8709名糖尿病参与者和17418名对照用于眼部疾病分析,以及6689名糖尿病参与者和13378名对照用于视力分析。使用截至2021年1月的住院记录确定眼部疾病。使用视力表评估视力。
在中位随访11.0年期间,分别确定了3874例、665例和616例白内障、青光眼和AMD新发病例。糖尿病诊断年龄越小,糖尿病与新发眼部疾病之间的关联越强。2型糖尿病(T2D)在<45岁[风险比(95%置信区间):2.71(1.49 - 4.93)]、45 - 49岁[2.57(1.17 - 5.65)]、50 - 54岁[1.85(1.13 - 3.04)]或50 - 59岁时诊断[1.53(1.00 - 2.34)]的个体,独立于糖化血红蛋白,患AMD的风险更高。T2D在<45岁[风险比(95%置信区间):2.18(1.71 - 2.79)]、45 - 49岁[1.54(1.19 - 2.01)]、50 - 54岁[1.60(1.31 - 1.96)]或55 - 59岁时诊断与白内障风险增加相关。仅<45岁时诊断的T2D与青光眼风险增加相关[风险比(95%置信区间):1.76(1.00 - 3.12)]。1型糖尿病(T1D)相关的AMD、白内障和青光眼的风险比(95%置信区间)分别为4.12(1.99 - 8.53)、2.95(2.17 - 4.02)和2.40(1.09 - 5.31)。在多变量调整分析中,<45岁时诊断为T2D的个体[β 95%置信区间:0.025(0.009,0.040)]的LogMAR增加更大。与T1D相关的LogMAR的β(95%置信区间)为0.044(0.014,0.073)。
糖尿病诊断年龄越小,新发眼部疾病的相对风险越大,视力丧失越严重。